The antibiotic vancomycin, recommended as first-line treatment for infection caused by the deadly superbug C. difficile (C. diff), may not be living up to its promise, according to new research. The ...

“We were able to show that the natural compound argyrin B is highly effective against CDI: both in laboratory experiments and ...

SEATTLE, April 3, 2025 /PRNewswire/ -- In a landmark achievement for its pioneering spirulina-based drug development platform, Lumen announced today top-line results from the sentinel cohort of its ...

Antibiotics can disrupt gut microbiota, leading to potential recurrences of Clostridioides difficile infections (CDI). New therapies like fecal microbiota transplantation (FMT) and monoclonal ...

Fecal microbiota transplantation (FMT), shown to be effective in the treatment of recurrent Clostridioides difficile infection (CDI), also shows significant benefit in the treatment of primary CDI, ...

C. diff is a horrible disease that can cause significant morbidity. It can and often does recur and kills around 30,000 Americans every year. We have made progress in prevention and treatment, but ...

Paul Feuerstadt, MD, FACG, AGAF, discusses how testing for Clostridioides difficile is recommended for hospitalized patients or outpatients with new-onset, unexplained diarrhea who have risk factors ...

Clostridioides difficile infections often spring up because the bacterium takes advantage of a weakened microbiome following treatment with antibiotics for other diseases. (iStock / Getty Images Plus) ...

Clostridioides difficile (C. diff) can either be a dangerous adversary or coexist peacefully in the human gut—depending on the circumstances. C. diff is usually present in small amounts in the gut and ...